| Q3 2025 Revenue | $53.7M | CFO |
| Q3 Non-GAAP Gross Margin | 49.6% | CFO |
| Q3 Non-GAAP OpEx | $37.9M | CFO |
| Q3 Non-GAAP Operating Loss | $11.3M | CFO |
| Q3 Net Loss | $13.3M | CFO |
| Q3 Loss Per Share | $0.07 (217.4M shares) | CFO |
| Q4 2025 Revenue Guidance | $54M–$60M ($57M midpoint) | CFO |
| Q4 Non-GAAP Gross Margin Guidance | ~47% | CFO |
| Q4 Non-GAAP OpEx Guidance | $36.5M | CFO |
| Q4 Net Loss Per Share Guidance | $0.07 (220M shares) | CFO |
| Strategic Backlog (2025) | $7.4B | CEO |
| Strategic Backlog Excl. Wuxi | $6.1B | CEO |
| Cash (incl. restricted) at Q3 End | $171.2M | CFO |
| Wuxi Sale Proceeds (gross) | ~$135M cash | CFO |